Showing results (2251-2260 of 3,160) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|October 31, 2021
Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic reviewLily J Andrews, Zak A Thornton, Saanwalshah S Saincher, et al.
Neuro-Oncology|November 1, 2021
EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adultsDidier Frappaz, Girish Dhall, Matthew J Murray, et al.
Neuro-Oncology|September 25, 2021
Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibitionRohit Rao, Rong Han, Sean Ogurek, et al.
Neuro-Oncology|April 5, 2022
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumorsBenjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, et al.
Neuro-Oncology|April 9, 2022
Adult brain tumors in Sub-Saharan Africa: A scoping reviewUlrick Sidney Kanmounye, Claire Karekezi, Arsene Daniel Nyalundja, et al.
Neuro-Oncology|August 25, 2020
Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitorsYuyu He, Jie Li, Tomoyuki Koga, et al.
Neuro-Oncology|April 6, 2021
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experienceEudocia Q Lee, Wendy Selig, Clair Meehan, et al.
Neuro-Oncology|April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomasYao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
Neuro-Oncology|October 18, 2012
Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomasAgustí Alentorn, Yannick Marie, Catherine Carpentier, et al.
Neuro-Oncology|October 24, 2012
Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomasNathalie L Jansen, Christoph Schwartz, Vera Graute, et al.
Pageof 316